Perchè gli animali non sono soggetti ad attacchi cardiaci -Dr. M.Rath

More documents

Recommendations

Info

12 DOCUMENTAZIONE Ginter E. (1978) Marginal vitamin C deficiency, lipid metabolism, and atherosclerosis (Carenza marginale di vitamina C, metabolismo dei lipidi e aterosclerosi). Lipid Research 16: 216-220. Ginter E. (1991) Vitamin C deficiency, cholesterol metabolism, and atherosclerosis (Carenza di vitamina C, metabolismo del colesterolo e aterosclerosi). Journal of Orthomolecular Medicine 6: 166-173. Guraker A, Hoeg JM, Kostner G, Papadopoulos NM, Brewer HB Jr. (1985) Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment (I livelli di lipoproteina Lp(a) si abbassano con trattamento a base di neomicina e niacina). Atherosclerosis 57: 293-301. Halliwell B, Gutteridge JMC (1985) Free radicals in biology and medicine (I radicali liberi in biologia e medicina). Oxford University Press, London, New York, Toronto. Harwood HJ Jr, Greene YJ, Stacpoole PW (1986) Inhibition of human leucocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by ascorbic acid. An effect mediated by the free radical monodehydroascorbate (L’inibizione dell’attività del leucocita umano 3-idrossi-3metilglutaril coenzima A riduttasi mediante acido ascorbico. Un effetto mediato dal radicale libero monodeidro-ascorbato). Journal of Biological Chemistry 261: 7127-7135. Hearn JA, Donohue BC, Ba’albaki H, Douglas JS, King SBIII, Lembo NJ, Roubin JS, Sgoutas DS. (1992) Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty (L’utilità della lipoproteina(a) serica come predittore di ristenosi in seguito ad angioplastica coronarica transluminale percutanea). The American Journal of Cardiology 68: 736-739. Hennekens, C. Vedi: Rimm EB (1993) e Stampfer (1993). Hermann WJ JR, Ward K, Faucett J. (1979) The effect of tocopherol on highdensity lipoprotein cholesterol (L’effetto del tocoferolo sul colesterolo legato alle lipoproteine ad alta densità). American Journal of Clinical Pathology 72: 848-852. Hemilä H. (1992) Vitamin C and plasma cholesterol (La vitamina C e il colesterolo plasmatico). In: Critical Reviews in Food Science and Nutrition 32 (1): 33-57, CRC Press Inc., Florida. Hodis H, Azen S, Qian D, et. al. (1996) Effect of Supplementary Antioxidant Vitamin Intake on Carotid Arterial Wall Intima-Media Thickness in a Controlled Clinical Trial of Cholesterol Lowering (L’effetto dell’integrazione di vitamine antiossidanti sullo spessore dell’intima-media caroti- 329
PERCHÉ GLI ANIMALI NON SONO SOGGETTI AD ATTACCHI CARDIACI E GLI UOMINI SÌ! dea in un trial clinico controllato sulla riduzione del colesterolo). Circulation 94(10): 2369-72. Hoff HF, Beck GJ, Skibinski CI, Jürgens G, O’Neil J, Kramer J, Lytle B. (1988) Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients (Il livello serico di Lp(a) come predittore di stenosi venosa dopo intervento chirurgico di bypass coronarico nei pazienti). Circulation 77: 1238-1244. Iseri LT. (1986) Magnesium and cardiac arrhythmias (Magnesio e aritmie cardiache). Magnesium 5: 111-126. Iseri LT, French JH. (1984) Magnesium: Nature’s physiologic calcium blokker (Il magnesio: il calcio-antagonista fisiologico naturale). American Heart Journal 108: 188-193. Jacques PF, Hartz SC, McGandy RB, Jacob RA, Russell RM. (1987) Ascorbic acid, HDL, and total plasma cholesterol in the elderly (Acido ascorbico, HDL e colesterolo plasmatico totale nelle persone anziane). Journal of the American College of Nutrition 6: 169-174. Kamikawa T, Kobayashi A, Emaciate T, Hayashi H, Yamazaki N. (1985) Effects of coenzyme Q-10 on exercise tolerance in chronic stable angina pectoris (Gli effetti del coenzima Q10 sulla tolleranza di esercizio nell’angina pectoris stabile cronica). American Journal of Cardiology 56: 247-251. Koh ET (1984) Effect of Vitamin C on blood parameters of hypertensive subjects (L’effetto della vitamina C sui parametri del sangue dei soggetti ipertesi). Oklahoma State Medical Association Journal 77: 177-182. Korbut R. (1993) Effect of L-arginine on plasminogen-activator inhibitor in hypertensive patients with hypercholesterolemia (L’effetto dell’L-arginina sull’inibitore attivatore plasminogeno nei pazienti ipertesi con ipercolesterolemia). New England Journal of Medicine 328 [4]:287-288. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. (1981) Lipoprotein Lp(a) and the risk for myocardial infarction (La lipoproteina Lp(a) e il rischio di infarto miocardico). Atherosclerosis 38: 51-61. Kurl S, Tuomainen TP, Laukkanen JA, et. al. (2002) Plasma vitamin C modifies the association between hypertension and risk of stroke (La vitamina C plasmatica modifica l’associazione fra ipertensione e rischio di ictus). Stroke 33 (6):1568-73. Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen P. (1988) Effective and safe therapy with coenzyme Q10 for cardiomyopathy (Terapia efficace e sicura con il coenzima Q-10 nella cardiomiopatia). Klinische Wochenschrift 66: 583-590. 330
Page 1 and 2:
Dr. Matthias Rath, M.D. Perché gli
Page 3 and 4:
Tutti gli eserciti del mondo messi
Page 5 and 6:
Prima edizione © 2007 Dr. Rath Edu
Page 7 and 8:
4 Ipertensione 103 Il Programma vit
Page 9 and 10:
8 Dr. Rath aiuta a diminuire i fatt
Page 11 and 12:
Perché gli animali non sono sogget
Page 13 and 14:
Perché gli animali non sono sogget
Page 15 and 16:
PERCHÉ GLI ANIMALI NON SONO SOGGET
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Note
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Note
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Note
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Note
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Note
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Note
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280: PERCHÉ GLI ANIMALI NON SONO SOGGET
Page 329: PERCHÉ GLI ANIMALI NON SONO SOGGET
Page 341: Il Dr. Matthias Rath insieme con il
show all

Perchè gli animali non sono soggetti ad attacchi cardiaci -Dr. M.Rath

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?